Generic AB H12025 review and valuation update

Update: 2025-09-11

Description

Quick recap of the solid company performance from Generic in H1, despite poor stock performance. A valuation update at the end.

Disclaimer, this is not financial advice. An investment carries severe risk of capital loss.

Comments

In Channel

Generic AB H12025 review and valuation update

2025-09-1107:00

Betsson AB - $BETS-B.ST

2025-09-1009:26

Medistim H12025 review and valuation update

2025-09-0503:59

Value investing trap 1 - Working capital

2025-08-1308:29

Evolution AB - $EVO - En route towards multiple expansion

2025-08-1107:12

Bahnhof AB - $BAHN

2025-08-0607:15

Bergman & Beving AB - $BERG

2025-07-1006:13

Bouvet ASA - $BOUV

2025-07-0906:35

Veteranpoolen AB - $VPAB

2025-07-0905:59

Brdr. A&O Johansen - $AOJ

2025-07-0907:53

Medistim ASA - $MEDI

2025-02-2807:02

Opter AB - $OPTER

2025-02-2606:50

Generic AB - $GENI.ST

2025-02-1711:02

Evolution AB rant

2025-02-1407:17

Why invest in nordic small cap stocks

2025-02-1406:47

00:00

#box-pro-ellipsis-175761467008650{-webkit-line-clamp:2;}Generic AB H12025 review and valuation update